◆英語タイトル:Takara Bio Inc (4974) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7493
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It offers clinical development of gene therapies for cancer treatment. Takara develops and commercializes medical technologies such as cell and gene therapies for cancer and AIDS. The company also develops original research reagents, scientific instruments, and contracted research services that utilize new genetic and cell engineering technologies. It supports biotechnology research by offering basic research and drug discovery and development services. Takara is headquartered in Kusatsu, Japan.
Takara Bio Inc (4974) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Takara Bio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Takara Bio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Takara Bio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Takara Bio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Takara Bio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Takara Bio Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Partnerships 11
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
WaferGen Bio-systems Enters into Distribution Agreement with Takara Bio 12
Takara Bio Enters into Agreement with Integrated DNA Technologies 13
WaferGen Biosystems Enters into Research Agreement with Women’s College Research Institute 14
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 15
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 16
WaferGen Biosystems Enters Into Co-Marketing Agreement With Qiagen 17
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 18
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 19
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 20
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 21
Takara Bio Enters Into Licensing Agreement With InVivoScribe Technologies For FLT3-ITD 22
Equity Offering 23
WaferGen Bio-systems Raises USD17.25 Million in Public Offering of Common Stock 23
Takara Bio Raises USD112 Million in Public Offering Of Common Stock 24
Acquisition 25
Takara Bio Acquires WaferGen Bio-Systems 25
Takara Bio Acquires Rubicon Genomics for USD75 Million 27
Takara Bio Inc – Key Competitors 28
Takara Bio Inc – Key Employees 29
Takara Bio Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Nov 28, 2017: Takara Bio: Consolidated Financial Statements for the Second Quarter Ended September 30, 2017 32
Legal and Regulatory 34
Oct 15, 2018: CAP-LAP certification of clinical testing laboratory for Takara Bio’s cancer genetic testing in Osaka University Hospital 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Takara Bio Inc, Medical Equipment, Key Facts, 2018 2
Takara Bio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Takara Bio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Takara Bio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Takara Bio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Takara Bio Inc, Deals By Market, 2012 to YTD 2018 8
Takara Bio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Rubicon Genomics Raises USD2 Million in Venture Financing 10
Rubicon Genomics Enters Into Licensing Agreement With University Of Michigan 11
WaferGen Bio-systems Enters into Distribution Agreement with Takara Bio 12
Takara Bio Enters into Agreement with Integrated DNA Technologies 13
WaferGen Biosystems Enters into Research Agreement with Women's College Research Institute 14
Rubicon Genomics Enters Into Distribution Agreement With GenoMax Technologies For DNA Library Prep Kits 15
Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics 16
WaferGen Biosystems Enters Into Co-Marketing Agreement With Qiagen 17
Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service 18
WaferGen Biosystems Enters Into Agreement With Integrated DNA Technologies 19
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 20
Rubicon Genomics Enters Into Technology Integration Agreement With Kreatech Diagnostics 21
Takara Bio Enters Into Licensing Agreement With InVivoScribe Technologies For FLT3-ITD 22
WaferGen Bio-systems Raises USD17.25 Million in Public Offering of Common Stock 23
Takara Bio Raises USD112 Million in Public Offering Of Common Stock 24
Takara Bio Acquires WaferGen Bio-Systems 25
Takara Bio Acquires Rubicon Genomics for USD75 Million 27
Takara Bio Inc, Key Competitors 28
Takara Bio Inc, Key Employees 29
Takara Bio Inc, Other Locations 30
Takara Bio Inc, Subsidiaries 30
Takara Bio Inc, Joint Venture 31
List of Figures
Takara Bio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Takara Bio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Takara Bio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Takara Bio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Takara Bio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Takara Bio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Takara Bio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Takara Bio Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8